Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2025

Renounceable Rights Issue

28 February 2025 by Karen Mobbs

Renounceable Rights Issue

Categories 2025, ASX Announcements

Biotron Investor Webinar

4 March 202526 February 2025 by Michelle Miller

Biotron Investor Webinar

Categories 2025, ASX Announcements

Appendix 3B – SPP

24 February 202521 February 2025 by Audrey Thomson

Appendix 3B – SPP

Categories 2025, ASX Announcements

Offer Document

24 February 202521 February 2025 by Audrey Thomson

Offer Document

Categories 2025, ASX Announcements

Letter to Shareholders

24 February 202521 February 2025 by Audrey Thomson

Letter to Shareholders

Categories 2025, ASX Announcements

Quarterly Report 31 December 2024

3 February 2025 by Audrey Thomson

Quarterly Report 31 December 2024

Categories 2025, ASX Announcements, Quarterly Reports

Report on Activities for the Quarter ended 31 December 2024

3 February 2025 by Audrey Thomson

Report on Activities for the Quarter Ended 31 Dec 2024

Categories 2025, ASX Announcements
Newer posts
← Previous Page1 Page2 Page3
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 25 June 2025        Legal Notices and Privacy
Cleantalk Pixel